Cancer Treatments for All: A Health Equity Panel
Clinical trials are the most important and reliable means available to provide scientific evidence for developing better therapies for cancer patients. Ensuring that all cancer patients have the opportunity to participate in clinical trials is imperative to the advancement of cancer care. Despite an overall decline in U.S. cancer deaths since 1991, not all patients have benefited equally from advances in prevention, early detection, precision medicine and targeted cancer treatments.
Join Stand Up To Cancer’s Heath Equity Committee leaders and patients for a conversation about the importance and complexities of health equity, and how we can bridge the gap to develop new cancer treatments we know will be effective for all.
Share this idea
Additional Supporting Materials
- The importance of inclusion in clinical trials for effective care management for cancer patients
- A better understanding of the complexities inherent in health equity
- Key ways we can work together to narrow existing gaps in cancer care
- Sung Poblete, PhD, RN, President and CEO, Stand Up To Cancer
- Edith Perez, MD, Serene M. and Frances C. Durling Professor of Medicine, Mayo Clinic College of Medicine and Chair, Stand Up To Cancer Health Equity Committee, Mayo Clinic/Stand Up To Cancer
- TBD TBD, Stand Up To Cancer Health Equity Committee Member, Stand Up To Cancer
- TBD TBD, Cancer Patient or Survivor (TBD), Stand Up To Cancer
Kim Warden, Comms Mgr, Stand Up To Cancer